Immune to Cancer: The CRI Blog
-
When AIDS Was a Cancer
Before AIDS was recognized as an immune disorder, it was seen as a cancer. Find out what…
-
Two Immunotherapies Clear Important Regulatory Hurdles
The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…
-
Making Pancreatic Cancer a Target for Immunotherapy
Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.
-
How do you help patients find their hope?
Cynthia, an oncology nurse at Mount Sinai Hospital, has a front row seat for immunotherapy. Hear what…
-
Immunotherapy Today: The View from ASCO
Once again, immunotherapy stole the show at the world’s largest annual cancer meeting.
-
Immunotherapy All the Rage at AACR
Researchers at this year's AACR annual meeting couldn’t stop talking about the promise of immunotherapy.
-
Putting a Hurt on Pancreatic Cancer
CRI postdoc Ingunn Stromnes, PhD, shows that dismantling a tumor’s defense shield makes it vulnerable to immune…
-
Do Bacteria Cause Cancer?
In honor of colorectal cancer awareness month, a look back at our understanding of the role of…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.